← 홈

전체 프로그램

ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 139개
CGTBiologicstaleBaylor College of MedicinePhase 1

CD19.CAR-multiVST for Group A (CD19.CAR-multiVST for Group A)

Non-hodgkin Lymphoma; Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 DISCONTINUED
CGTBiologicstaleBaylor College of MedicinePhase 1

CD19.CAR-multiVST for Group B (CD19.CAR-multiVST for Group B)

Non-hodgkin Lymphoma; Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 DISCONTINUED
CGTBiologicstaleThe First Affiliated Hospital o…Phase 2

CD19/22 CART (CD19/22 CART)

Relapsed Non Hodgkin Lymphoma; Refractory Non-Hodgkin Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleChina Immunotech Pharmaceutical…Phase 1

CD19/CD20 Dual-CAR-T cells (CD19/CD20 Dual-CAR-T cells)

B-cell Non-Hodgkin's Lymphoma · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 DISCONTINUED
CGTBiologicstalePeking UniversityPhase 1

CD19/CD20-directed Chimeric Antigen Receptor T Cells (CD19/CD20-directed Chimeric Antigen Receptor T Cells)

B Cell Non-Hodgkin's Lymphoma · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleShanghai Cell Therapy Group Co.…Phase 1

CD19/CD20/BCMA CAR T cells (CD19/CD20/BCMA CAR T cells)

Non-Hodgkin Lymphoma, B-cell · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleUniversity of Colorado, DenverPhase 1

CD19x22 CAR T Cells (CD19x22 CAR T Cells)

Non-Hodgkin Lymphoma; B-cell Non-Hodgkin Lymphoma (B-NHL) · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleShanghai Longyao Biotechnology …Phase 1

CD20 CAR-T (CD20 CAR-T)

Relapsed and Refractory B Cell Lymphoma; Non-Hodgkin Lymphoma · CD20

#CD20#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleBaylor College of MedicinePhase 1

CD7.CAR/28zeta CAR T cells (CD7.CAR/28zeta CAR T cells)

T-cell Acute Lymphoblastic Lymphoma; T-non-Hodgkin Lymphoma · T-cell Acute Lymphoblastic Lymphoma

#T-cellAcuteLymphoblasticLymphoma#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleCaribou Biosciences, Inc.Preclinical

Caribou-sponsored investigational therapy (Caribou-sponsored investigational therapy)

Lymphoma, Non-Hodgkin; Relapsed Non-Hodgkin Lymphoma · FRα

#FR#CGT#Preclinical#세포유전치료#CAR-T+5
임상시험 1상태 ACTIVE
AntibodystaleHeidelberg UniversityPhase 2

Cyclophosphamide, Pentostatin, Rituximab (Cyclophosphamide, Pentostatin, Rituximab)

Immunocytoma/Morbus Waldenström; B-Cell Non-Hodgkin's Lymphoma · Immunocytoma/Morbus Waldenström

#ImmunocytomaMorbusWaldenstrm#Antibody#Phase2#항체#면역항체+5
임상시험 1상태 ACTIVE
AntibodystaleZeneus PharmaPhase 2

R-COMP (Cyclophosphamide, oncovin, myocet, prednisone & rituximab, Cyclophosphamide, oncovin, myocet, prednisone & rituximab (R-COMP))

Aggressive Non-Hodgkin's Lymphoma in the Elderly. · Aggressive Non-Hodgkin's Lymphoma in the

#AggressiveNon-HodgkinsLymphomain#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
ADCBiologicstaleNew York Medical CollegePhase 2

DOC Group C (DOC Group C)

Non-hodgkin Lymphoma; Hodgkin Lymphoma · Non-hodgkin Lymphoma

#Non-hodgkinLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleGenmabPhase 2

Doxorubicin Hydrochloride [HCl] (Doxorubicin Hydrochloride [HCl])

Non-Hodgkin Lymphoma · Non-Hodgkin Lymphoma

#Non-HodgkinLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
CGTBiologicstaleUniversity of Kansas Medical Ce…Phase 1

DuoCAR20.19.22-D95 (DuoCAR20.19.22-D95)

B-Cell Non-Hodgkin Lymphoma; B-cell Acute Lymphoblastic Leukemia · B-Cell Non-Hodgkin Lymphoma

#B-CellNon-HodgkinLymphoma#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
AntibodystaleThe Lymphoma Academic Research …Phase 1

Everolimus and rituximab (Everolimus and rituximab)

Non-Hodgkin's Lymphomas · Non-Hodgkin's Lymphomas

#Non-HodgkinsLymphomas#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
CGTBiologicstaleBaylor College of MedicinePhase 1

Expansion Phase: CD19.CAR/28 and CD19.CAR/28137 T cells (Expansion Phase: CD19.CAR/28 and CD19.CAR/28137 T cells)

Non-Hodgkin Lymphoma; Chronic Lymphocytic Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleThe First Affiliated Hospital o…Phase 1

GB5005 CART (GB5005 CART)

Non-hodgkin Lymphoma; Refractory Lymphoma · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
AntibodystaleChangchun GeneScience Pharmaceu…Phase 1

Gentulizumab (Gentulizumab)

Solid Tumor; Non-Hodgkin Lymphoma · Solid Tumor

#SolidTumor#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 DISCONTINUED
CGTBiologicstaleChongqing Precision Biotech Co.…Phase 1

Invivo CAR-T (Invivo CAR-T)

B-Acute Lymphoblastic Leukemia; B Cell Non-Hodgkin's Lymphoma · B-Acute Lymphoblastic Leukemia

#B-AcuteLymphoblasticLeukemia#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING

5 / 7 페이지

← 이전다음 →